Vascular Biogenics Ltd reports results for the quarter ended in March - Earnings Summary

Notable Labs

17/05/2022 14:31

* Vascular Biogenics Ltd  VBLT.OQ  reported a quarterly
adjusted
loss of 13 cents​​ per share for the quarter ended in March. The
mean expectation of five analysts for the quarter was for a loss
of 11 cents per share.
    * Revenue fell 38.9% to $113.00 thousand from a year ago; 
analysts expected $200.00 thousand. 
    * Vascular Biogenics Ltd's reported EPS for the quarter was
a loss
of 13 cents​.
    * The mean earnings estimate of analysts had fallen by
about 20%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Vascular Biogenics Ltd shares had fallen by 13.6% this
quarter and lost 25.9% so far this year.
    * The company reported a quarterly loss of $10.43 million.
    * Wall Street's median 12-month price target for Vascular
Biogenics Ltd is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 17 at 01:31 p.m.  ​All
figures in US dollars unless otherwise stated